Loading...

We're making the next batch
Ships in ~7 days or less
These products are for laboratory research only and not intended for medical use. They must be handled by qualified professionals in controlled laboratory environments. This compound has not been evaluated by the FDA and is not approved for human or veterinary use.
Third-party tested for purity, identity, and quantity.
This ipamorelin is supplied as a lyophilized (freeze-dried) white powder at ≥98% purity as determined by HPLC analysis and confirmed by mass spectrometry. A certificate of analysis (CoA) is provided with each lot, detailing purity, molecular weight confirmation, and sterility testing results. This product is manufactured for research laboratory use only.
Published preclinical research has employed ipamorelin in rat and mouse pituitary cell cultures to assess GH secretion, as well as in whole-animal rodent models examining bone growth, GI motility, and GH axis dynamics. Cell-based receptor binding assays using GHSR-1a-expressing recombinant cell lines have also been used to characterize its pharmacological selectivity relative to other GHSR agonists.
Ipamorelin's primary molecular target is the growth hormone secretagogue receptor type 1a (GHSR-1a), the endogenous receptor for ghrelin. It functions as a GHSR-1a agonist, stimulating GH release from somatotroph cells. Research suggests it has negligible affinity for cortisol, ACTH, or prolactin pathways at GH-stimulating concentrations, distinguishing its receptor selectivity profile from earlier-generation GHRPs in comparative pharmacology studies.
Quality controlled from start to finish. No outsourcing.
Ipamorelin is a synthetic pentapeptide ghrelin-receptor (GHSR) class ligand. Supplied as a research reagent for in vitro laboratory assays only; not for human or animal use.
These references are provided for research purposes only. Citations do not imply endorsement or approval of this product for any specific application.